- Air Liquide will support 70,000 respiratory patients in Madrid over five years.
- The contract includes care for COPD and sleep apnea patients.
- COPD cases are projected to increase by 23% globally by 2050.
- An app and platform will be used for data collection and health outcome measurement.
Contract Overview
The Community of Madrid has awarded Air Liquide a five-year contract to provide home care for 70,000 patients with respiratory conditions. This decision followed a public tender process where Air Liquide's proposal was recognized for its operational excellence and effective use of digital and AI solutions.
Patient Care and Conditions
The contract focuses on patients with chronic obstructive pulmonary disease (COPD) and sleep apnea. Home healthcare services aim to help chronic patients maintain autonomy and quality of life. According to the WHO and the European Respiratory Society, COPD cases are expected to rise by 23% globally by 2050.
Technological Integration
Air Liquide's approach includes personalized support, telemonitoring, and digital tools to enhance patient interaction and care. An app and platform are used for data collection and health outcome measurement, integrated into the healthcare professionals' portal for shared access and proactive monitoring.
Multidisciplinary Team
The care team comprises nurses, physiotherapists, pulmonologists, clinical psychologists, speech therapists, and nutritionists. They receive ongoing training and biannual skills assessments to ensure high-quality home respiratory therapies.
